News

Discover all our latest news and upcoming events…

Our News:

Stay up-to-date with the latest news from IHU RespirERA: projects, events, collaborations, discoveries, and innovations in respiratory health.

Filtrer par :
News
Smoking and cancer: discovery of a new genetic signature
A major international study has just revealed a new genetic signature associated with smoking across several types of tumors. Professor Paul Hofman, Director of the RespirERA Institute, discusses the insights gained from this discovery and the perspectives it opens up for research.
The RespirERA Institute is taking part in PADDEL, a project exploring links between emerging pollutants, the environment and lung cancer.
Featured
PADDEL Project: Better Understanding the Impact of Emerging Pollutants on Lung Cancer
The RespirERA Institute is taking part in the national PADDEL project, which will analyse links between emerging pollutants and lung cancer by combining medical and environmental data.
The RespirERA Institute acquires the NovaSeq X to accelerate genomic and multi-omics research on respiratory diseases.
Featured
The RespirERA Institute strengthens its research capabilities with the acquisition of the NovaSeq X
With the acquisition of the NovaSeq X, the RespirERA Institute strengthens its genomics platform to accelerate the analysis of respiratory diseases and support the development of more personalised medicine.
The RespirERA Institute is participating in the SOPHiA GENETICS Innovation Summit 2026, dedicated to innovations in precision medicine, biomarkers, and artificial intelligence.
News
Liquid biopsy and precision medicine: the challenges of large-scale deployment
Professor Paul Hofman, Director of the RespirERA Institute, took part in the SOPHiA GENETICS Innovation Summit 2026, an international event dedicated to innovations in precision medicine. This event...
A review published in Lung Cancer highlights the role of biomarkers in guiding the use of new targeted treatments for lung cancer.
Publication
Lung cancer: better identifying patients who may benefit from new targeted treatments
RespirERA Institute experts review biomarkers guiding new targeted treatments in lung cancer.
A study involving the RespirERA Institute helps improve the selection of targets for cancer immunotherapy.
Publication
Cancer immunotherapy: a study involving the RespirERA Institute opens new perspectives to better select therapeutic targets
A study involving the RespirERA Institute highlights the importance of shared epitopes to better select targets for future cancer immunotherapies.

Upcoming Events

Discover IHU RespirERA's upcoming events: seminars, conferences, and meetings dedicated to innovation and research on respiratory diseases.

Congrès international à Nice pour explorer l'impact de l’IA en pathologie thoracique et ses applications cliniques en santé respiratoire.
Events
AI in the Next World of Thoracic Pathology
10/06/2026
- 10/07/2026
In Nice, an international congress will explore the role of artificial intelligence in making thoracic pathology diagnosis faster, more precise and more personalized.